{"id":"W3102193847","doi":"10.1161/circ.142.suppl_3.14170","title":"Abstract 14170: Reduction in Venous Thromboembolism With Rivaroxaban versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD","year":2020,"lang":"en","type":"article","venue":"Circulation","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Rivaroxaban; Aspirin; Clopidogrel; Placebo; Clinical endpoint; Randomization; Internal medicine; Randomized controlled trial; Revascularization; Surgery; Cardiology; Anesthesia; Warfarin; Myocardial infarction; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002883152,0.0004708022,0.00145252,0.0003156177,0.0001172572,0.0007696182,0.000357051,0.0008822848,0.002746006],"category_scores_gemma":[0.001854422,0.000185502,0.001100093,0.0002556379,0.000613047,0.0003940105,0.0002743166,0.001155936,0.0003713244],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002675657,"about_ca_system_score_gemma":0.0004219488,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009389772,"about_ca_topic_score_gemma":0.0001439827,"domain_scores_codex":[0.998942,0.0007128002,0.00006271747,0.0001018473,0.0001136664,0.00006689612],"domain_scores_gemma":[0.9993591,0.0002622757,0.0002070378,0.00003429427,0.00003974644,0.00009749945],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4704155,0.01374924,0.007599836,0.007189789,0.003606311,0.0002939344,0.0003166976,0.001299917,0.07535753,0.003029887,0.002990318,0.414151],"study_design_scores_gemma":[0.36334,0.5143337,0.0873927,0.001080591,0.002983408,0.001021258,0.0002136011,0.002109373,0.01109692,0.004432501,0.01189349,0.0001026258],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.93866,0.05155962,0.001674652,0.002553561,0.0006774706,0.000648698,0.0004287711,0.0000792517,0.003718011],"genre_scores_gemma":[0.9820617,0.01199834,0.001724179,0.001226948,0.0008338178,0.0005159034,0.0003025222,0.00001072565,0.001325811],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002883152,"threshold_uncertainty_score":0.01524776,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0173785666039225,"score_gpt":0.2311607860355561,"score_spread":0.2137822194316336,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}